Pott Christian, Steinritz Dirk, Bölck Birgit, Mehlhorn Uwe, Brixius Klara, Schwinger Robert H G, Bloch Wilhelm
Department of Molecular and Cellular Sport Medicine, German Sport University Cologne, Institutsgebäude 1, 9.OG, Carl-Diem-Weg 6, Rm. 911, D-50933 Cologne, Germany.
Am J Physiol Cell Physiol. 2006 May;290(5):C1437-45. doi: 10.1152/ajpcell.00005.2005. Epub 2005 Dec 7.
In endothelial cells, two ways of endothelial nitric oxide (NO) synthase (eNOS) activation are known: 1) translocation and 2) Akt-dependent phosphorylation of the enzyme at Ser(1177) (Ser(1177) eNOS). We have recently shown that agonist-induced Ser(1177) eNOS phosphorylation also occurs in human myocardium (10). In this study, we investigated the Ca(2+) dependency of these two mechanisms in human atrium. Therefore, atrial tissue was obtained from patients who underwent coronary artery bypass operations. In immunohistochemical experiments, the translocated form of eNOS and phosphorylated Ser(1177) eNOS were labeled using specific antibodies. eNOS translocation was measured in the absence and presence of the Ca(2+) chelator BAPTA before and after application of BRL 37344 (BRL), a beta(3)-adrenoceptor agonist that increases eNOS activity (34). In the absence of BAPTA, BRL time dependently increased the staining intensity of translocated eNOS, whereas in the presence of BAPTA, this effect was blunted. In contrast, BRL clearly increased the staining of phosphorylated Ser(1177) eNOS even in the presence of BAPTA. This observation was confirmed using Western blot analysis. Using the NO-sensitive dye diaminofluorescein, we have demonstrated that BRL induced a strong NO release. This effect was completely abolished in the presence of BAPTA but was unaffected by LY-292004, an inhibitor of phosphatidylinositol 3-kinase activity and eNOS phosphorylation. Although Ca(2+) dependent, neither the translocation of eNOS nor NO release was changed by the adenylate cyclase activator forskolin. In conclusion, 1) in human atrial myocardium, BRL-induced eNOS translocation but not Ser(1177) eNOS phosphorylation is dependent on intracellular Ca(2+). 2) In atrial myocardium, eNOS-translocation and not Ser(1177) eNOS phosphorylation is responsible for generating the main amount of NO. 3) Although Ca(2+) dependent, eNOS translocation and NO release could not be mimicked by adenylate cyclase activation as a mediator of beta-adrenergic stimulation.
在内皮细胞中,已知内皮型一氧化氮合酶(eNOS)激活有两种方式:1)转位;2)该酶在丝氨酸(Ser)1177位点(Ser(1177) eNOS)的Akt依赖性磷酸化。我们最近发现,激动剂诱导的Ser(1177) eNOS磷酸化在人类心肌中也会发生(10)。在本研究中,我们调查了人类心房中这两种机制对钙离子(Ca(2+))的依赖性。因此,从接受冠状动脉搭桥手术的患者获取心房组织。在免疫组织化学实验中,使用特异性抗体标记eNOS的转位形式和磷酸化的Ser(1177) eNOS。在应用能增加eNOS活性的β(3)-肾上腺素能受体激动剂BRL 37344(BRL)之前和之后,在存在和不存在Ca(2+)螯合剂BAPTA的情况下测量eNOS转位。在不存在BAPTA时,BRL随时间依赖性增加转位eNOS的染色强度,而在存在BAPTA时,这种效应减弱。相反,即使在存在BAPTA的情况下,BRL也明显增加磷酸化的Ser(1177) eNOS的染色。使用蛋白质印迹分析证实了这一观察结果。使用对一氧化氮敏感的染料二氨基荧光素,我们证明BRL诱导强烈的一氧化氮释放。在存在BAPTA时这种效应完全消除,但不受磷脂酰肌醇3激酶活性和eNOS磷酸化抑制剂LY - 292004的影响。尽管依赖Ca(2+),但腺苷酸环化酶激活剂福斯可林既不改变eNOS的转位,也不改变一氧化氮的释放。总之,1)在人类心房心肌中,BRL诱导的eNOS转位而非Ser(1177) eNOS磷酸化依赖于细胞内Ca(2+)。2)在心房心肌中,产生主要量一氧化氮的是eNOS转位而非Ser(1177) eNOS磷酸化。3)尽管依赖Ca(2+),但作为β-肾上腺素能刺激的介质,腺苷酸环化酶激活不能模拟eNOS转位和一氧化氮释放。